Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92.4M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-18.2K
-
Total reported value, excl. options
-
$0
-
Value change
-
-$70.7K
-
Number of sells
-
-1
Significant Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q4 2023
1 filings reported holding VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value as of Q4 2023.
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 92.4M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (7.1M shares), Avoro Capital Advisors LLC (4M shares), FMR LLC (1.51M shares), VANGUARD GROUP INC (1.26M shares), BlackRock Inc. (1.14M shares), GEODE CAPITAL MANAGEMENT, LLC (430K shares), STATE STREET CORP (389K shares), NORTHERN TRUST CORP (199K shares), BML Capital Management, LLC (180K shares), and MML INVESTORS SERVICES, LLC (148K shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.